Intravenous immunoglobulin-based adjuvant therapy for severe COVID-19: a single-center retrospective cohort study

Intravenous immunoglobulin-based adjuvant therapy for severe COVID-19: a single-center retrospective cohort study

Abstract Objective Coronavirus disease 2019 (COVID-19) is a major challenge facing the world. Certain guidelines issued by National Health Commission of the People's Repubilic of China recommend intravenous immunoglobulin (IVIG) for adjuvant treatment of COVID-19. However, there is a lack of cl...

Full description

Bibliographic Details
Main Authors:	Xiao Hou, Li Tian, Lei Zhou, Xinhua Jia, Li Kong, Yitao Xue, Hao Hao, Xianqing Meng, Feihu Zhang, Xiaobin Dong
Format:	Article
Language:	English
Published:	BMC 2021-05-01
Series:	Virology Journal
Subjects:	SARS-CoV-2 COVID-19 IVIG Mortality Mechanical ventilation Hospital length of stay
Online Access:	https://doi.org/10.1186/s12985-021-01575-3

Similar Items

Clinical efficacy of intravenous immunoglobulin therapy in critical ill patients with COVID‐19: a multicenter retrospective cohort study
by: Ziyun Shao, et al.
Published: (2020-01-01)

Multimodality treatment in immunocompromised patients with severe COVID‐19: the role of IL‐6 inhibitor, intravenous immunoglobulin, and haemoperfusion
by: Nophol Leelayuwatanakul, et al.
Published: (2021-04-01)

The Production Processes and Biological Effects of Intravenous Immunoglobulin
by: Ana Filipa Barahona Afonso, et al.
Published: (2016-03-01)

Hemolysis induced cross-matching difficulty with intravenous immunoglobulin: a case report
by: Achyut Sharma, et al.
Published: (2018-09-01)

Joint analysis of duration of ventilation, length of intensive care, and mortality of COVID-19 patients: a multistate approach
by: Derek Hazard, et al.
Published: (2020-08-01)

The use of intravenous immunoglobulin in pediatric rheumatology
by: Zbigniew Żuber, et al.
Published: (2014-07-01)

Intravenous immunoglobulin-associated hemolysis: risk factors, challenges, and solutions
by: Mohamed M
Published: (2016-10-01)

Immunomodulation: Immunoglobulin Preparations Suppress Hyperinflammation in a COVID-19 Model via FcγRIIA and FcαRI
by: Fabian Bohländer, et al.
Published: (2021-06-01)

Neutralizing activities against seasonal influenza viruses in human intravenous immunoglobulin
by: Onodera H, et al.
Published: (2017-03-01)

Intravenous immunoglobulin remain a source of bias in the interpretation of infectious disease serology among clinicians
by: A.K. Van der Bij, et al.
Published: (2020-12-01)

Antiplatelet Antibodies Do Not Predict the Response to Intravenous Immunoglobulins during Immune Thrombocytopenia
by: Thomas Rogier, et al.
Published: (2020-06-01)

Pharmacokinetics of Intravenous Immunoglobulin and Outcome of Guillain-Barre Syndrome
by: J Gordon Millichap
Published: (2010-01-01)

Treatment of allopurinol-induced toxic epidermal necrolysis with high dose corticosteroids and intravenous immunoglobulins
by: Mehmet Akyürek, et al.
Published: (2019-07-01)

Intravenous immunoglobulin treatment in a patient with adrenomyeloneuropathy
by: Jønch Aia, et al.
Published: (2012-09-01)

The effects of hair regrowth with intravenous immunoglobulin (IVIG) therapy. Two case reports
by: Joseph A. Cahill, et al.
Published: (2017-07-01)

Clinical false positives resulting from recent intravenous immunoglobulin therapy: case report
by: Janarthanee Suresh, et al.
Published: (2021-03-01)

Timing of infections in patients with primary immunodeficiencies treated with intravenous immunoglobulin (IVIg)
by: Parwinder K. Gill, et al.
Published: (2018-08-01)

Initial intravenous immunoglobulin doses should be based on adjusted body weight in obese patients with primary immunodeficiency disorders
by: Rohan Ameratunga
Published: (2017-12-01)

Combined intravenous immunoglobulin and baricitinib treatment for severe COVID-19 with rhabdomyolysis: A case report
by: Hao-Yu Wu, et al.
Published: (2021-09-01)

Time spent in prior hospital stay and outcomes for ventilator patients in long-term acute care hospitals
by: Berna Demiralp, et al.
Published: (2021-03-01)

Efficacy of Intravenous immunoglobulin and phototherapy in the management of extreme-hyperbilirubinaemia: A Case Report
by: Olufunke Bosede Bolaji, et al.
Published: (2017-08-01)

Obesity May Not Be Associated with 28-Day Mortality, Duration of Invasive Mechanical Ventilation and Length of Intensive Care Unit and Hospital Stay in Critically Ill Patients with Severe Acute Respiratory Syndrome Coronavirus-2: A Retrospective Cohort Study
by: Sjaak Pouwels, et al.
Published: (2021-06-01)

A triple combination of treatments on moderate COVID-19
by: Bao ChunMiao, et al.
Published: (2021-05-01)

Timing of Intravenous Immunoglobulin Treatment and Risk of Coronary Artery Abnormalities in Children with Kawasaki Disease
by: Aswine K. Bal, et al.
Published: (2014-10-01)

Intravenous Immunoglobulin Protects Against Severe Pandemic Influenza Infection
by: Steven Rockman, et al.
Published: (2017-05-01)

Use of Intravenous Immunoglobulins in Sepsis Therapy—A Clinical View
by: Dominik Jarczak, et al.
Published: (2020-08-01)

High-Dose Intravenous Immunoglobulin in Skin Autoimmune Disease
by: Jochen H. O. Hoffmann, et al.
Published: (2019-06-01)

The clinical response of West Nile virus neuroinvasive disease to intravenous immunoglobulin therapy
by: Zvi Shimoni, et al.
Published: (2012-01-01)

Efficacy and Effect of Inhaled Adenosine Treatment in Hospitalized COVID-19 Patients
by: Massimo Caracciolo, et al.
Published: (2021-03-01)

Clinical Practice Guidelines for Home Management of Intravenous Immunoglobulin Therapy
by: Taylor, Rosemary
Published: (2019)

Could Intravenous Immunoglobulin Collected from Recovered Coronavirus Patients Protect against COVID-19 and Strengthen the Immune System of New Patients?
by: Samir Jawhara
Published: (2020-03-01)

COVID-19 healthcare cost and length of hospital stay in Turkey: retrospective analysis from the first peak of the pandemic
by: Ergun Oksuz, et al.
Published: (2021-10-01)

Retrospective correlation analysis of plasma Immunoglobulin G and clinical performance in CIDP
by: Lars Kjøbsted Markvardsen, et al.
Published: (2019-05-01)

Efficacy of intravenous immunoglobulin monotherapy in patients with cutaneous lupus erythematosus: results of proof-of-concept study
by: Christa Ky, et al.
Published: (2015-03-01)

Mucous membrane pemphigoid affecting the epiglottis and response to intravenous immunoglobulin therapy
by: Anes Yang, et al.
Published: (2018-03-01)

Binding Performance of Human Intravenous Immunoglobulin and 20(S)-7-Ethylcamptothecin
by: Yong-Chun Liu, et al.
Published: (2018-09-01)

Hemolysis From Intravenous Immunoglobulin in Obese Patients With Kawasaki Disease
by: Khanh-Van Y. Van Anh, et al.
Published: (2020-04-01)

Delivery of subcutaneous immunoglobulin by rapid “push” infusion for primary immunodeficiency patients in Manitoba: a retrospective review
by: Graham Walter, et al.
Published: (2020-05-01)

Intravenous Immunoglobulin G Suppresses Heat Shock Protein (HSP)-70 Expression and Enhances the Activity of HSP90 and Proteasome Inhibitors
by: Richard J. Jones, et al.
Published: (2020-08-01)

Coronary spastic angina after the administration of intravenous immunoglobulin in myasthenia gravis: a case report
by: Masaru Yanagihashi, et al.
Published: (2020-08-01)